aspect
of
doctor)
→
ReceivesAction
→
enrolled in the study
Typicality: | 0.523 |
Saliency: | 0.436 |
of a new lung cancer treatment | 6 | other |
for a period of 4 months | 4 | temporal |
patient → be enrolled in → the study | 18 |
patient → be enrolled in → study | 8 |
patient → be enrolled in → this study | 4 |
patient → enroll in → study | 3 |
patient → be enrolled into → the study | 3 |
negative | neutral | positive |
0.223 | 0.686 | 0.091 |
Raw frequency | 36 |
Normalized frequency | 0.436 |
Modifier score | 0.767 |
Perplexity | 73.279 |